Literature DB >> 10403079

Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.

A Zipursky1, E J Brown, H Christensen, J Doyle.   

Abstract

Transient Myeloproliferative Disorder (Transient Leukemia) is found in approximately 10% of newborn infants with Down Syndrome. It is characterized by the large numbers of megakaryoblasts in the peripheral blood, variable thrombocytopenia and, in a minority of cases, by a lethal course with hydrops fetalis or progressive hepatic fibrosis. Evidence is presented that this disease is truly leukemia, which, in most cases, recovers spontaneously. There is evidence that hematopoiesis is abnormal in Down Syndrome children who do not have leukemia. These abnormalities of red cells, platelets, and granulocytes are reviewed.

Entities:  

Mesh:

Year:  1999        PMID: 10403079

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  13 in total

1.  Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome.

Authors:  Sabine Dormann; Marcus Krüger; Roland Hentschel; Regina Rasenack; Brigitte Strahm; Udo Kontny; Charlotte Niemeyer
Journal:  Eur J Pediatr       Date:  2004-04-28       Impact factor: 3.183

2.  Role of multiplex reverse-transcriptase PCR for diagnosis of Acute myelosis in an infant with Down's syndrome.

Authors:  Jyoti Kotwal; M G Manoj; Ajay Malik; Kavita Sinha; Daljit Singh; Vibha Dutta
Journal:  Med J Armed Forces India       Date:  2013-02-23

3.  Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.

Authors:  Ming-Horng Tsai; Jia-Woei Hou; Chao-Ping Yang; Pong-Hong Yang; Shih-Ming Chu; Jen-Fu Hsu; Ming-Chou Chiang; Hsuan-Rong Huang
Journal:  Indian J Pediatr       Date:  2011-02-02       Impact factor: 1.967

4.  Some dynamic aspects of hematopoietic stem cells.

Authors:  David Dingli; Jorge M Pacheco
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

5.  Hematopoietic disorders in Down syndrome.

Authors:  John K Choi
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

6.  Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis.

Authors:  Myoung Ja Park; Manabu Sotomatsu; Kentaro Ohki; Kokoro Arai; Kenichi Maruyama; Tomio Kobayashi; Akira Nishi; Kiyoko Sameshima; Takeshi Takagi; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2013-12-14       Impact factor: 2.490

7.  Down syndrome with different hematological manifestations: a short series of 3 cases with review of literature.

Authors:  Prabhu Manivannan; Priavadhana Rajan Prasaad; Rakhee Kar; Debdatta Basu
Journal:  Indian J Hematol Blood Transfus       Date:  2012-02-01       Impact factor: 0.900

8.  Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation.

Authors:  Andrew J Woo; Karen Wieland; Hui Huang; Thomas E Akie; Taylor Piers; Jonghwan Kim; Alan B Cantor
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

9.  Whole chromosome aneuploidy: big mutations drive adaptation by phenotypic leap.

Authors:  Guangbo Chen; Boris Rubinstein; Rong Li
Journal:  Bioessays       Date:  2012-08-24       Impact factor: 4.345

10.  Prenatal diagnosis of transient abnormal myelopoiesis in a Down syndrome fetus.

Authors:  Gwang Jun Kim; Eun Sil Lee
Journal:  Korean J Radiol       Date:  2009-03-03       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.